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ABSTRACT: In 1947, Ernst Chain moved from Oxford to Rome, hired as head of a new biochemistry 
department and of a penicillin production pilot plant in the Istituto Superiore di Sanità (Higher 
Health Institute). Here, he managed to make Rome one of the most important centres in the 
international network of antibiotic science. However, the development of the state-operated 
centre was not easy. Political and economic pressures, exerted both from home and abroad, 
posed many obstacles to the plan devised by Domenico Marotta, the general director of the 
Institute. The paper reconstructs Chain’s venture in Rome, which lasted until 1964, while fram-
ing the history of the penicillin production plant in the context of diplomatic negotiations, 
national politics, and science policies.
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1. The Istituto Superiore di Sanità
The Istituto Superiore di Sanità (Higher Health Institute, ISS from now 
on) is one of the most important biomedical research institutions in Italy 1. 
 1. Historical accounts of the ISS can be found in: Paoloni, Giovanni. Il Laboratorio Chimico della 
Sanità. Dall’Istituto d’Igiene dell’Università di Roma all’Istituto Superiore di Sanità. In: Farina, 
Anna; Bedetti, Cecilia, eds. Microanalisi elementare organica. Collezione di strumenti. Roma: 
Istituto Superiore di Sanità; 2007, p. 9-61; Donelli, Gianfranco. La microscopia elettronica 
all’Istituto Superiore di Sanità dal 1942 al 1992: dai Laboratori di Fisica al Laboratorio di 
Ultrastrutture. Roma: Istituto Superiore di Sanità; 2008; Capocci, Mauro; Cozzoli, Daniele. 
The making of the Italian scientific research system: the case of Domenico Marotta (1886-
Mauro Capocci 
Dynamis 2011; 31 (2): 343-362
344
Particularly in the decades after the Second World War, it became one of 
the state-funded institutions that provided a model for scientific research. It 
combined public health tasks with pure and applied research, and also had 
an important role in spreading innovations in the life sciences: biochemistry, 
biophysics and molecular biology all found in the ISS an important training 
and research centre in the 1950s and 1960s. This made the institute one of 
the engines of scientific development in post-war Italy. 
Founded in 1934, it was the result of an agreement between the Italian 
government and the Rockefeller Foundation (RF). A few months after its 
opening, at the beginning of 1935, Domenico Marotta became its director: 
he would keep this position until his retirement in 1961. During this time, 
he managed to fully develop his vision, creating an institute able to compete 
at the international level, attracting important scientists from abroad, and 
finally creating a state-owned penicillin production plant.
The original mission of the ISS, as intended by the RF, was to pursue field 
work in the sector of public health, most likely similar to the endeavours the 
Foundation’s Health Division undertook in the first decades of the twentieth 
century in underdeveloped countries (e.g., Mexico and Brazil) 2. Accordingly, 
the first name of the ISS was Istituto di Sanità Pubblica (Institute of Public 
Health: the name was changed in 1942). RF was already present in Italy with 
a strong commitment in the fight against the «national disease», i.e. malaria; 
prevention of this and other scourges, together with general control and 
education tasks, was to be the main mission of the ISS, at least in the RF’s 
opinion. The Fascist Regime (and Marotta) strove to make the institute a 
large research establishment, similar to the Institut Pasteur in Paris, or the 
Johns Hopkins Medical School in Baltimore: a national body for any sort of 
chemical, medical and physical tests (mostly on food, drugs and chemicals) 
as well as a centre for scientific research. The Institute would have been a 
symbol of the new powerful nation the Fascist dictatorship was creating. 
Yet, when the new institution was inaugurated in 1934 (on April 21st, the 
alleged day of the foundation of Rome) only a few facilities were actually 
in use, and in the next decade the Institute could not be fully devoted to 
1974). Preprint of the Max Planck Institute for the History of Science. 2008; 361: 109-124. 
This paragraph is mainly based on the latter article, where detailed references can also be 
found.
 2. Farley, John. To cast out disease: a history of the International Health Division of the Rockefeller 
Foundation (1913-1951). Oxford: Oxford University Press; 2004.
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research. In the second half of the 1930s, the colonial war and the milita-
ristic policy of the Regime, as well as the ensuing embargo by the Society 
of Nations, resulted in an autarchic attitude and in the increased need by 
the Army for vaccines and drugs. As a consequence, the activities of the 
ISS were partly constrained: vaccines and sera production took a good 
deal of effort, as well as food chemistry and public health control duties. 
Some of the laboratories comprising the institute nonetheless carried out 
some research. Most notably, microbiology and bacteriology enjoyed the 
acquisition from Siemens of one of the few electron microscopes existing 
in Europe, and a particle accelerator was built, upon the request of Fermi’s 
group. The physicists from the University of Rome turned to the rich ISS in 
order to build this important research tool, and Marotta gladly welcomed 
and satisfied their request. Unfortunately, the 1 MeV Cockroft-Walton ac-
celerator was only completed in 1939, after Fermi’s flight and on the verge 
of war. Other important studies were developed by the malaria laboratory 
headed by Alberto Missiroli, related to the ecology of the anopheles and 
acquired immunity to the disease in humans.
The war hit Rome the hardest in 1943 and 1944, with repeated bom-
bings by the Allies. In July 1943, a massive attack aimed at the railway 
lines hit streets and buildings in the university area. The ISS suffered some 
damage, but was still working. Another blow came when the Germans, in 
the spring of 1944, left the town and confiscated the electron microscope, 
considered to be a strategic instrument. A new one was built in 1946 by 
the scientists and technicians of the institute, allegedly following the plans 
stealthily copied in the days before the Nazi confiscation 3.
After the war, in 1945, the ISS was one of the few existing and working 
scientific institutions in Italy. As the Institute was a technical and adminis-
trative body, it was quite easy for Marotta to avoid the recruitment of its 
personnel in the Army: the full functioning of the Institute was needed in 
order to produce important goods for the Nation. Marotta also managed 
to avoid the transfer of the Institute to the puppet state of the Repubblica 
Sociale Italiana, based in Northern Italy and under the Nazis’ control. 
Like all the other offices of the government, the ISS was to be moved. 
Marotta cunningly allowed the transfer of just a few people, but not the 
infrastructures and the scientific instruments: he would have gladly agreed 
 3. Donelli, n. 1, p. 8-10.
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for the transfer, but only after the provision of a functional building, with 
all the laboratories properly working. In the hard times of 1944-1945, this 
was quite unlikely to happen, and Marotta added that Rome was a better 
location for providing drugs and other useful chemicals produced by the 
institute to the Southern regions.
Marotta was also able to pass relatively untouched to the new democracy; 
accused of being a collaborationist, due to the important role he had had 
within the fascist bureaucracy, he provided some evidence of his antifascist 
stance. As a matter of fact, he never overtly opposed the Regime, though it 
appears that he was not a fervent supporter of Mussolini, especially in the 
last few years of the dictatorship. He was thus allowed to keep his position 4.
In the following years, Marotta could fully deploy his view of the ISS as 
a fundamental research centre, devoted to the scientific and technological 
development of the nation.
2. UNRRA’s plant and chain’s penicillin
Penicillin became a research subject in the Institute in 1944-1945. The 
alliance with the Nazis and the brutal consequences of the war most probably 
hindered the circulation of information regarding the new «miracle drug» 
before 1944: we know that even the more scientifically advanced Germany 
was quite late in attaching to penicillin its real value, though most of the 
publications were available in the Reich 5. Germans apparently did not forward 
the information to their Italian allies; in Italy some news came across with 
literature from neutral Switzerland 6. According to the head of the chemical 
department of the Milan-based pharmaceutical company Lepetit, «the 
 4. Marotta attitude towards the Fascist regime has been analyzed in Capocci, Mauro; Cozzoli, 
Daniele. The ISS during Fascism. Paper presented at the conference Science, scientist and 
totalitarian systems. Barcelona; 2008.
 5. Shama, Gilbert; Reinarz, Jonathan. Allied intelligence reports on wartime German penicillin 
research and production. Historical Studies in Physical and Biological Sciences. 2002; 32 (2): 
347-367; Wainwright, M. Hitler’s penicillin. Perspectives in Biology and Medicine 2004; 47 
(2): 189-98; Gaudillière, Jean-Paul; Gausemeier, Bernd. Molding national research systems: 
the introduction of penicillin to Germany and France. Osiris. 2005; 20: 180-202; Bud, Robert. 
Penicillin: triumph and tragedy. Oxford: Oxford University Press; 2007.
 6. Farmitalia. La chimica della terra [motion picture]. Piavoli, Mario. ZefiroFilm, producer. 2008, 30 
min, sound, color.
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study of penicillin in Italy began in early 1944» 7. In July 1944, in the journal 
published by the Medical School of the University of Rome, Il Policlinico, an 
account of the new drug discovered by the Americans appeared, though the 
literature cited is largely incomplete 8. In the same issue (p. 466), the journal 
bore a brief and unsigned note about penicillin treatment for gonococcal 
infection, reporting a study published in the Journal of American Medical 
Association in April 1944. In August, the physician Giuseppe La Cava of 
the University of Pisa, published a short review on the surgical uses of the 
new drug, based on the literature provided by the chief of public health 
services of the Allied Military Government 9. In October (though published 
in February the next year), a study on 110 ophthalmological patients was 
described by a clinician at the University of Rome 10; the source of penicillin 
was not mentioned. Another study involving penicillin was described in 
December 1944 and published in October 1945 by Roman physicians working 
in the Army Hospital (attached to the University General Hospital); the 
drug used was from Merck penicillin, «courtesy» of the American Army 
Command 11. They treated two young soldiers, admitted in September and 
October 1944 for extensive burns. In the summer of that year, the Allied 
Committee controlling the Country presented two cultures of penicillin 
to the General Direction for Public Health, which gave them to the ISS 12. 
The first studies conducted about the Penicillium mould were published in 
1945 in the scientific journal of the Institute, the Rendiconti of the ISS 13. 
These were several assays of the different methods for determining the 
 7. Carrara, Gino. L’industria farmaceutica italiana nel 1947 di fronte all’industria farmaceutica nel 
mondo. La Chimica e l’Industria. 1947; 29 (8-9): 208-210.
 8. Jandolo, Costantino. Un nuovo chemioterapico: la penicillina. Il Policlinico. Sezione pratica. 1944; 
51 (27-31): 425-433. The Allied troops entered Rome on June 6th, 1944. Most probably, the 
paper had been written before the liberation of Rome, so that access to the literature was 
difficult.
 9. La Cava, Giuseppe. La penicillina: sua storia, natura e applicazioni chirurgiche. Il Policlinico. 
Sezione pratica. 1944; 51 (32-35): 473-476.
 10. Bietti, G. B. La penicillina in oftalmologia. (Rassegna e contributi personali). Il Policlinico. Sezione 
pratica. 1945; 52 (6-7, 8-9): 33-54, 74-78.
 11. Corelli, F.; Iadevaia, F. Moderno trattamento generale e locale delle ustioni. La cura dello shock 
da ustioni col lattato di sodio per bocca e della sepsi con la penicillina. Il Policlinico. Sezione 
pratica. 1944; 52 (43-44): 457-467.
 12. Per la produzione della penicillina in Italia. Il Policlinico. Sezione pratica. 1944; 51 (32-35): 504.
 13. Scanga, Franco. Il controllo della sensibilità dei germi nella terapia penicillinica. Un metodo 
di ricerca semplice e di pratica applicazione. Rendiconti dell’Istituto Superiore di Sanità. 
1945; 8: 485-510; Scanga, Franco. La concentrazione della penicillina nel sangue e negli altri 
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concentration of penicillin in blood and urine according to various means 
of administration of the drug, and a long assay regarding the spectrum of 
activity of the antibiotic substance. Both papers are by Franco Scanga, head 
of the bacteriology laboratory and author of several studies on sulphamides 
before the war. He states in the papers to have used the Penicillium notatum 
strain nr. 1249, «the original one, coming from London» 14. Scanga used 
the surface fermentation technique: it was the easiest and cheapest if only 
a small quantity was needed. In his papers, he also reviewed the existing 
literature and proposed two new simpler methods for testing the sensitivity 
of bacteria and assaying the concentration of penicillin in the blood and 
other body fluids. In September the same year, Alexander Fleming visited 
the Institute and lectured there. The speaker in a newsreel by the Istituto 
Luce 15 states that, once the rumour had spread that Fleming was in Rome, 
the cameramen went out searching for the penicillin discoverer: «it was 
easier for them to find the scientist, than a single dose of the powerful 
medicament» 16.
Penicillin was still at the time a scarce resource 17. Yet, in 1945 some 
technologies were already available for industrial production by deep 
fermentation, though only implemented in the USA and Canada. The 
United Nations Relief and Rehabilitation Administration (UNRRA), the 
US-dominated organisation aimed at relieving the damages of the war, 
set up a large scheme to provide penicillin to several countries in Europe. 
Italy was included in this program, first by direct import of the drug 18, and 
later by the offer of a complete plant for production by deep fermentation. 
By means of a cable on 11 February 1946, UNRRA’s mission in Rome was 
liquidi organici. Importanza delle vie di somministrazione e del dosaggio. Metodi di ricerca. 
Rendiconti dell’Istituto Superiore di Sanità. 1945; 8: 511-542.
 14. Scanga, n. 13, 1945, p. 486. Though Scanga omitted the prefix, most probably he is talking 
about the P. notatum NRRL-1249 strain, used by the British for surface culture in the first 
efforts to produce penicillin on large scale.
 15. The Istituto Luce was the State owned institute for cinematographic information. Its archive 
is available on the web at www.archivioluce.it.
 16. Ospite in Italia lo scienziato scopritore della penicillina Alexander Fleming [motion picture]. 
Luce, Istituto, producer. 1945, 00:21 secs, sound, black and white.
 17. The story of its large scale production has been told in full detail by Hobby, Gladys L. Penicil-
lin: meeting the challenge. New Haven: Yale University Press; 1985.
 18. In mid-1945, UNRRA assigned to Italy for civilian use 2500 vials (each containing 100.000 OU) 
monthly, for five consecutive months. On this, La penicillina in Italia. Il Policlinico. Sezione 
pratica. 1945; 52 (23-24): 231.
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informed of the offer. The information was then handed over to the Italian 
Commissioner for Public Health, Gino Bergami, and only in April was the ISS 
informed. The offer consisted of a deep-fermentation penicillin production 
plant, plus the know-how needed for operating the equipment and thus 
some training for scientists. A clause to be respected regarded the fate of 
the production: it was meant neither for export, nor for commercial sale. 
The Italian Commissioner for Hygiene and Public Health gladly accepted 
the gift. According to a later account made in 1948 by Marotta himself, 
Bergami tried to implant the factory in Northern Italy, in order to be near 
to the productive core of the country. Yet UNRRA explicitly stated that the 
furnishing of the apparatus had to be «justified by Govt as part program 
rehabilitation previously existing Govt operated biological producing 
institutes» 19. For this reason, the ISS was probably the only suitable site 
for the new plant. At least another laboratory offered its premises for the 
penicillin factory: the State Quinine Laboratory in Turin, whose management 
wrote to the Prime Minister, to the High Committee for Hygiene and Public 
Health, to the Minister of Internal Affairs, to all the local authorities, in 
order to have it 20. It is somewhat remarkable that the management’s letter 
does not mention any official communication, anything like a public call 
for application; the information about the penicillin plant was obtained by 
newspaper articles. These articles reported on the decision (discussed in 
the Parliamentary commission in mid January, 1947) of adding 350 million 
ITL to the UNRRA fund, yet they did fail to inform the reader that the 
location for the factory was already chosen, and the commission was only 
deciding about the money to be added to the project.
In 1946, in fact, two ISS scientists had already spent several weeks in 
Toronto to obtain training in penicillin and fermentation biochemistry, in a 
plant similar to the one presented to Italy. Their training eventually proved 
of little use: the intended plant never went into operation.
Many reasons led to this apparent failure. On one side, many documents 
show that Marotta complained about the substantial disorganisation of 
the UNRRA shipping. There was neither a list of what was being sent, 
nor was the shipping made towards only one destination. Marotta was 
 19. Cable 01538, UNRRA Washington to UNRRA Rome, 11 Feb 1946. Rome, Archivio Centrale dello 
Stato (ACS) - series ISTISAN - Fabbrica di Penicillina (FP), box 24, folder 1/5.
 20. Commissione interna del Laboratorio del chinino di Stato in Torino, letter to ACIS, 12 Feb 1947, 
Rome ACS – Presidenza del Consiglio dei Ministri (PCM) 55-58 no. 39792.23 1.1.2.
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quite unnerved, as were the US representatives of UNRRA, by the delays 
encountered by the project. The problems denounced by Marotta were in 
fact real, and to the shipping issues a location issue was added, because 
the ISS had to search for a suitable area in order to create the new factory. 
Once the area was located (a few hundred meters from the institute’s main 
building), it had to be cleared of the people working and living there. This 
proved to take longer than expected.
Marotta had another reason to gain some time. Between the end of 
1946 and the beginning of 1947 an Italian tour was organised for Ernst 
Boris Chain. The invitation to Rome had been the primer: in mid-August 
1946 Marotta asked Chain to lecture at the ISS, and later in the same 
year the British Council and various local institutions arranged a series 
of lectures on penicillin and antibiotics in the late winter of 1947 in seve-
ral Italian cities. During the negotiations for the Italian tour, Chain and 
Marotta started their formal collaboration: already in February of 1947 
the Oxford chemist was paid 75,000 ITL for his «technical and scientific 
services provided in the design of the plants of the penicillin factory» 21. 
According to Chain’s recollection, his first answer to Marotta’s request 
for advice was sharp:
«The opinion I gave him was that it was utterly uneconomical to put up 
the technically antiquated UNNRA plant and in view of the high efficiency 
of penicillin production by private industry there was no case for the State 
to interfere in this industry» 22.
Instead, he suggested a radical change to the project. The UNRRA 
funds, he argued, would have been more useful if aimed at the creation 
of an international research centre in biochemistry that included all the 
necessities for research, including a pilot plant for fermentation. Marotta 
most probably discussed the new project with the Commissioner for Public 
Health and some members of the Government: an agreement was reached 
to create a factory, as agreed with UNRRA, and the pilot plant Chain 
 21. Document in ACS – ISTISAN FP, box 24, folder 3.
 22. Chain, Ernst B. My Activities at the Istituto Superiore di Sanità. Wellcome Library, London; EBC 
Archive, Box 12, C13, p. 1. The manuscript was probably written by Chain himself in 1957/58. 
Being Chain’s personal memories, we should not take them as a perfect reconstruction of 
what had actually happened. In fact, Chain’s reconstruction sometimes does not coincide 
with other documentary sources.
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devised. He also managed to get additional funding from the government, 
amounting to 350 million ITL. This supplement was justified by the need 
for a new building and the land to be bought, though during the debate in 
the parliamentary commission the issue of scientific research was raised: 
was the new facility aimed solely at penicillin production, or was it going 
to be devoted to research? The Commissioner for Public Health in January 
1947 gave assurance that the funds were not destined for generic research 
purposes, though they may also be used for «other researches, controls, 
etc. etc» 23.
However, curiously enough, Chain’s participation in the endeavour 
is never made clear in the letters and documents exchanged with the 
American and UNRRA representatives. The several long memoranda sent 
to the American cultural attaché fail to mention the hiring of, or even the 
counselling by, the Nobel prize winning scientist, one of the living symbols of 
the wonder drug. Neither is Chain’s name ever raised in the correspondence 
with the government officers. This silence extended until late summer 1948, 
when it was finally made clear that Chain would be in charge of the new 
biochemical research centre attached to the penicillin factory. 
In February 1948 the ceremony took place to lay the foundation stone 
of the new factory; the US Ambassador James Clement Dunn, together 
with the Italian Prime Minister Alcide De Gasperi, was there. The pictures 
also show Ernst Chain there, though in the reports his name is never 
associated with the endeavour, and he is there solely as being one of the 
great characters in the penicillin saga 24. Similarly, the ambassador did not 
mention in his address the research facility and the experimental character 
of the «pilot plant», nor did Chain in his speech 25. Dunn also noted the 
end of the same year as the date for the beginning of penicillin production. 
He was quite optimistic in his forecast. At the end of June, the Director of 
the US Foreign Aid Mission to Italy, Leon Dayton, appeared very upset at 
the limited development of the project, despite the US having granted 200 
million ITL in advance. Dayton adds two points to his complaint. The first 
 23. Camera dei Deputati. Le commissioni della Costituente per l’esame dei Disegni di Legge. Rome; 
1985, p. 366.
 24. Many pictures of the event, as well as many others images about the history of the institute 
are held by the ISS photo archive. The pictures may be accessed via the following website: 
http://www.iss.it/arst/index.php?lang=1
 25. Registrazione effettuata in occasione della cerimonia di posa della prima pietra dell’istituto 
italiano per la fabbricazione della penicillina, 1948, ACS – ISTISAN FP, box 24, folder 3.
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refers to the agreement signed by the Italian and US governments, in order 
to have all US financed projects in operation by June 30th 1948. The second 
is the fact that rumours were spreading of two penicillin factories being 
«under construction by private firms (…), one of which may be producing 
before the end of 1948, the other in 1949» 26.
3. The ISS between business and politics
Dayton was correct: in the following years two plants began to operate in 
Rome. One was constructed by the Laboratori Palma, acting as a subsidiary 
of the American pharmaceutical firm Squibb, on the northern side of the 
town 27. The other one was named Leo, and located in the Eastern periphery: 
the know-how and patents for penicillin production came from the Danish 
company Løvens Kemiske Fabrik, whose technicians and scientists came 
to Rome in 1947 to build the plant and put it into operation 28. The Leo 
company in Italy was owned by Giovanni Armenise, who also owned the 
influential newspaper Giornale d’Italia as well as an important private bank. 
He had also passed relatively untouched from Fascism to the new Republic, 
despite being a member of several fascist institutions. The negotiations 
between Armenise and the Danish partner were concluded in early 1947 
and in the spring of the same year an agreement was already signed. The 
deal provided for an immediate payment of 500,000 Danish Crowns (slightly 
more than 100,000 USD) and exclusive sales in the following countries: 
Switzerland, Austria, Yugoslavia, Albania, Greece, Romania, Bulgaria, Iran, 
 26. Leon Dayton to the High Commissariat of Hygiene and Public Health, 29 Jun, 1948, ACS – IS-
TISAN FP, box 24, folder 5.
 27. Apparently, the Palma-Squibb plant also produced streptomycin (at least in 1952: see Ministero 
delle Finanze, letter to Alto Commissariato per l’Igiene e la Sanità (ACIS), 26 February 1952. 
ACS - PCM 55-58 no. 39792.23 1.1.2). It is not clear if it ever produced penicillin.
 28. Larsen, Alfred. Har De lyst til at tage til Italien. Ballerup: Løvens kemiske Fabrik; 1995. Leo was 
also the first firm to apply for a penicillin factory construction in Spain, in June 1947. San-
tesmases, Maria-Jesus. Distributing penicillin: the clinic, the hero and industrial production 
in Spain, 1943-1952. In: Quirke, Viviane; Slinn, Judy, eds. Perspectives on twentieth-century 
pharmaceuticals. Oxford: Peter Lang; 2010, p. 91-117.
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Iraq, Turkey 29. The Italian company was also obliged to pay the Danes a 
tenth of the revenues obtained 30.
In this context, the ISS project for a State operated factory, directed 
by an outstanding scientist, was perceived as a potential obstacle. Thus, it 
is quite understandable why Marotta was so discreet about Chain’s arrival. 
Furthermore, there was another reason for not blowing the horn. Chain was 
not at all a beloved figure in the US. As most of his biographers underline, 
he was denied the visa to enter the United States for many years, despite 
the Nobel Prize and endorsement from the World Health Organisation. The 
main reason for this friction is to be found in the fact that in the aftermath 
of WWII Chain had many contacts with Eastern European countries (such 
as Czechoslovakia and the USSR) regarding penicillin production. Yet Chain’s 
behaviour was not dictated by ideological adherence: his perspective was 
rather economic. In addition, he was also outspokenly critical of the honours 
the US had paid to Alexander Fleming, and of the understatement of the 
role of the Oxford group in the making of the wonder drug 31. 
The worries about the supposed competition between the State-run 
factory and its private counterparts were not completely ill-founded. The 
ISS plant, in full gear, could produce quite a large quantity of penicillin, 
though less than the output claimed by the two privately operated facto-
ries 32. In addition, the ISS was limited by the non-commercial clause signed 
with UNRRA. Yet, the public factory could access a substantial share of the 
market, such as the Army, the public hospitals and the zoo-technical service 
centres. In May 1947, the director of Leo wrote to Marotta, wondering if 
 29. It shall be noted that none of these countries were in the US sphere of influence. As a matter 
of fact, in the immediate aftermaths of the Second World War, Leo was the most important 
competitor to US firms. However its relevance in the penicillin field somewhat faded as 
American influence grew over the years.
 30. Letter from Cisitalia to ISS, 3 May, 1947. ACS - ISTISAN FP box 24, folder 5.
 31. Bud, n. 5, chapter 3. Chain never missed the chance to underline that Fleming did not grasp 
the importance of his 1929 discovery of the mould’s antibacterial activity, stating that most 
of the credit for the wonder drug was to be ascribed to the painstaking chemical work 
carried out in Oxford (and thus, by himself ). Chain, Ernst B. A short history of the penicillin 
discovery from Fleming’s early observations in 1929 to the present time. In: Parascandola, 
John, ed. The history of antibiotics. A symposium. Madison, WI: American Institute of the 
History of Pharmacy; 1980, p. 15-29.
 32. Leo’s plant had a declared output of 2,000 billions O.U./year, while Italy need was about of 80 
billions or 300 billions (depending on the estimates). Squibb’s (Palma) plant was declared 
to have a 480 billions OU/year potential. In 1955, the ISS plant produced 950 billions OU. 
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the new penicillin factory of the ISS was going to be a hindrance on their 
new Italian-Danish endeavour. Marotta firmly denied this: 
«We think that no interference shall be between the penicillin production 
plant to be set in this Institute, and any similar plant that may be set up by 
private companies. This, provided that the State will not decide to establish 
a production monopoly. But regarding this point, to our knowledge, the High 
Commissioner for Health and Public Health, Gino Bergami has already given 
precise assurances to the parliamentary commission» 33.
In the same letter, though, Marotta also pointed to possible flaws in penicillin 
production by private firms, underlining the importance of official control 
over this production. This implied the need for a public body that would 
be able to compensate for potential shortcomings. Cisitalia’s worries were 
not completely ill-founded, though, since the possibility of nationalising 
drug production always loomed. In 1951 a bill regarding the intervention 
of the State in the production of drugs was discussed at length, following a 
1949 proposal by the socialist MP Umberto Pieraccini. The bill was never 
approved, thanks to the opposition from Government and widespread 
contempt from industry. The Chemical Industries Association in fact 
harshly protested against the «ignorant slanders» addressed against private 
companies during the parliamentary debate, affirming the «dignity and the 
rectitude of the national production industry» 34.
As a matter of fact, in the field of antibiotics the competition between 
public and private firms never really took place. Leo Penicillina enjoyed a 
de facto monopoly in penicillin production. While many firms imported 
and packaged the drug in Italy, Leo alone was able to produce it on its 
premises. Leo’s production began in 1949 35: Fleming went there to visit 
the plant. With Chain only a few kilometres away from the Leo factory, 
Fleming’s visit may be considered a display of the company’s pride. In the 
next few years, Leo also took advantage of the high import levy imposed 
on penicillin: foreign antibiotics were thus more expensive than Italian 
supplies, though the production price was lower in the US and UK than in 
Italy. Furthermore, the National Committee for Prices (the body in charge 
 33. Marotta to Cisitalia, 20 May, 1947. Rome, ACS – ISTISAN FP box 24, folder 5.
 34. Telegram from Associazione Nazionale Industria Chimica and Associazione Industriali Chimico-
Farmaceutici to Prime Minister, 16 Nov 1951, ACS/PCM 48-50 no. 1.5.1 2041.10.26.
 35. Larsen, n. 28.
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of setting the prices of some goods) based the base price on the Italian 
production cost: this meant that the import levy, based on the nominal 
value of the good, was extremely heavy for foreign companies, and that 
the Italian firm could be competitive, at least in the national market. The 
relatively small scale, and the cumbersome deal reached with the Danish 
company, implied a high production cost for Italian companies, which had 
to be compensated in the market. Confindustria (the national organisation 
representing Italian manufacturing and services companies) thus called 
for protection against the dumping actions by foreign firms, that «would 
make national production unfeasible» 36. This lobbying pressure on the 
Government was clearly ascribed to Count Giovanni Armenise, at least by 
the Communist MP Luigi Preti 37. Curiously enough, though somewhat usual 
in Italian politics, the protectionist attitude was heralded by the right wing 
parties (the Government), while the left opposed the import levy. According 
to the Christian Democrat MP Gaspare Pignatelli, it was peculiar to hear 
a communist call for an act that would have worsened Italian dependence 
on the USA 38. It must also be noted that Pignatelli was a member of the 
stockholders council in the Banca Nazionale dell’Agricoltura, the private 
bank owned by Armenise.
The strong protection for Italian penicillin endured only until 1952, 
since in later years the import levy was lowered. Yet two years were 
probably enough for granting the Leo plant enough profits to repay the 
initial investment. Since the ISS started penicillin production in the same 
year, the de facto monopoly granted to Leo was also long enough to cause 
some shortcomings: in 1950-1951, the Korean war had led to a crunch in the 
penicillin export from the USA, with antibiotics being considered a strategic 
good. This had generated a relative shortage in many countries where local 
production and alternative supply channels were not available. In Italy, 
a harder situation regarded streptomycin (with no local manufacturers), 
whereas national production (i.e., Leo’s product) managed to cover a 
fraction of the demand for penicillin. Still, scarcity was experienced for 
both medicaments until the state stepped in and bought the drugs from 
costly suppliers outside the USA. The emergency was rapidly overcome, 
 36. Letter from Confindustria to Prime Minister, 29 June, 1950. Rome ACS - PCM 55-58 no. 39792.23 
1.1.2.
 37. Camera dei Deputati (CD). Resoconto stenografico. 9 Jul 1952, p. 39748.
 38. CD. Resoconto stenografico. Seduta pomeridiana, 28 Feb 1951, p. 26608.
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and in 1952 the High Commissariat for Hygiene and Public Health (ACIS) 
antibiotic reserves were fully restored.
In this situation, once the production at the ISS was ready to start in 
June 1952, the late entrance into the industrial penicillin market caused 
some difficulties. When the ISS was looking for potential buyers, the ACIS 
declined the offer because of the stocks bought in the preceding year; the 
public health and assistance institutions, as well as the national market, 
were fully provided with the antibiotic 39.
It was also too late for the ISS to exert any form of price control, a 
function claimed to be one of the purposes of the penicillin plant when a 
new substantial fund (350 million ITL) was requested from the government 
in 1950-1951 40. As a matter of fact, penicillin price dropped all over the 
world in a few months 41: in 1954 the Italians paid for their prescription 
«wonder drug» 18% more than the British, but 8% less than the French, 14% 
less than the Spanish, and a significant 81% less than the West Germans 42. 
Furthermore, Marotta’s attempt to enter the commercial market, selling at 
least «the products of experiments … that otherwise would be lost», did 
not yield any result 43.
The ISS penicillin factory, at its inception, was thus framed within the 
two alternatives of protectionism and liberalism. The latter was supported 
by the USA, pushing for the free market, and thus helping the penetration 
of American companies, such as Squibb, and protecting their investments 
abroad. Protectionism was on the other hand the typical stance of Italian 
industry, dedicated as it was to creating a protected national environment 
helping its own competitiveness 44. To an Italian businessman like Armenise 
(furthermore, one raised within the Fascist Regime), the role of the pilot plant 
and the biochemical laboratory headed by Chain at ISS as an innovation 
 39. Letter from ACIS to ISS, 23 Jun 1952. Rome, ACS – ISTISAN, series Amministrazione e Personale 
(AMM), box 127.
 40. CD, Commissioni in sede legislativa, Undicesima commissione, 14 Mar 1951, p. 506.
 41. The price tumbled very fast: in January 1947, 10 million units cost 21 USD; in 1952, 1.15 USD; 
in 1955, 0.44 USD. Steele, Henry. Patent restrictions and price competition in the ethical drugs 
industry. Journal of Industrial Economics. 1964; 12 (3): 198-223.
 42. Valier, Valerio. I prezzi delle specialità medicinali in Italia e all’estero. Rassegna chimica. 1955; 
7 (5): 5-14.
 43. Letter from Marotta to ACIS. 9 Dec 1957. Rome, ACS – ISTISAN, series Direzione (DIR), box 79.
 44. This opinion was also expressed in a veiled manner by Lepetit’s chemist Gino Carrara in 
Carrara. L’industria farmaceutica italiana nel 1947 di fronte all’industria farmaceutica nel 
mondo. 
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centre, a public research establishment created to boost Italian technological 
development, was hard to understand and to acknowledge. As a matter of 
fact, this innovation role was the overall result of the Marotta and Chain 
association, at least in its first decade. The Fabbrica and the research centre 
were contiguous, and Chain himself considered the coupling of a large scale 
industrial ward with the research centre as a major strength of the project 45. 
The pilot plant was to serve innovation in industrial biotechnology and 
biochemistry, and the factory would immediately benefit from the engineering 
developments achieved by researchers and technicians. The strong focus 
on production and engineering was also at the core of the World Health 
Organisation’s interest in the new ISS centre, that soon became the site 
for international training courses and educational activities in the field of 
antibiotics 46. Many guests, both from Italy and abroad, came to visit the 
centre: what is more surprising is that these guests were not only academic 
scientists, but also researchers and technicians working in private companies 
(again, Italian and international, such as Beecham, Merck and Astra). Italian 
pharmaceutical industries greatly benefitted from cooperation with the 
ISS, and they gained an important place in the global antibiotics market. 
For example, an Italian firm managed to become the official supplier of 
tetracycline hydrochloride for the US Military Medical Supply Agency for 
three consecutive years, from 1958 to 1960 47. Italian companies could boast 
low prices also because of the patent policy: drugs were not patentable in 
Italy until 1979 48. The four largest Italian companies (Leo, Palma-Squibb, 
Lepetit, Farmitalia) overtly acknowledged Marotta’s and the ISS’ role in 1955, 
by presenting the Institute with a statue portraying Alexander Fleming, a 
few months after his death.
 45. Chain, Ernst B. Aims and function of the International Research Centre of Chemical Microbiol-
ogy, 1951. Wellcome Library, London; EBC Archive, Box 12, C10.
 46. Expert Committee On Antibiotics. Report on the First Session. Geneva, 11-15 April. WHO Techni-
cal Report Series. 1950; 26: 1-12.
 47. Steele, n. 41. The name of the company is not yet known, and thus it’s not clear whether it 
benefitted from ISS cooperation. 
 48. Marotta directed a Governmental Commission about drug patentability, whose final report 
endorsed drug patents. Still, the interest of small pharmaceutical companies —those with 
no R&D to be protected by patents— prevailed.
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4. Conclusion
A detailed discussion of the political and economic implications of the 
Penicillin factory established at the ISS is beyond the scope of this preprint. 
Yet, we can draw some conclusions about its importance. 
On the one hand, the scientific heart of the matter must be underlined. 
In Chain’s laboratory a fundamental result was obtained, isolating the 
6-APA (6-Aminopenicillanic acid), i.e. the active core of all penicillins 49. 
This result was also at the core of a bitter controversy with Beecham’s 
laboratory, since Chain acted as a consultant for the British company, and 
two of its researchers spent several months in Rome. Beecham thus took 
advantage of Chain’s work to secure an important advance in the production 
of semi-synthetic penicillins. Furthermore, many technological innovations 
were implemented, thanks to the very skilful engineers working side-by-
side with Chain, especially in creating a completely controlled cycle of 
fermentation, where every step of the process was carefully monitored. 
The rate of failed fermentation was thus lower than with the traditional 
processes. The engineers that helped Chain in creating the plant were also 
responsible for the next centre where Chain moved after leaving Rome, the 
new biochemical laboratory (with a pilot plant for fermentation studies) 
at Imperial College, London. While in Rome, Chain also patented some 
important analytical instruments (a two-dimensional chromatographer, 
built within the Institute workshops), and broadened his research, including 
many aspects of carbohydrate metabolism. A lot of other important research 
was carried out by Chain’s collaborators, ranging from microbial genetics 
to many aspects of biochemistry and fermentation 50. 
 49. Ballio, A. et al. Penicillin derivatives of p-aminobenzylpenicillin. Nature. 1959; 183 (4655): 180-181 
Batchelor. F. R. et al. Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations. 
Nature. 1959; 183 (4656): 257-8. For a later account of the discovery, though only from the 
British side: Rolinson, G. N.; Geddes, A. M. The 50th anniversary of the discovery of 6-amino-
penicillanic acid (6-APA). International Journal of Antimicrobial Agents 2007; 29 (1): 3-8. 
 50. Following Bud’s suggestion, for a detailed account of Chain’s scientific activity we point at 
Abraham, Edward. Ernst Boris Chain. 19 June 1906-12 August 1979. Biographical memoirs 
of Fellows of the Royal Society. 1983; 29: 43-91. With regard to the work carried on in the 
ISS International Centre of Biological Chemistry, the reader may turn to Gualandi, Giuseppe. 
Il Centro Internazionale di Chimica Microbiologica ed il suo capo: E. B. Chain. Rendiconti 
dell’Accademia Nazionale delle Scienze detta dei XL. Memorie di Scienze Fisiche e Naturali. 
1999; 5th series, 23 (2nd part, t. 1): 211-213 and Capocci and Cozzoli, n. 1.
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On the other hand, we point out the character of the ISS as a possible 
node of a network of innovation within the Italian technological environment. 
Still, soon after Chain left in 1961 (though he officially resigned only in 
1964), the ISS entered a crisis, following Marotta’s retirement and the legal 
prosecution that involved his management in 1964, and even involved Chain 
and the centre he directed. The Institute’s role as an innovation spreader 
was lost, while the last evidence of activity for the pilot plant is found in 
the spring of 1964, in the middle of the storm that was hitting the institute. 
Harsh criticisms were directed against Marotta’s and Chain’s vision of the ISS 
and consequently of the penicillin plant 51. Marotta was accused of having 
perverted the primary mission of the ISS, which had to be focussed on 
public health. In this view, repeatedly expressed by the ISS microbiologist 
Giuseppe Penso 52, the role of technological innovation in biomedical 
sciences was not part of this mission, but only the result of Marotta’s own 
grandeur. Still, the penicillin production plant may be framed in a larger 
context. Marotta used it in order to obtain some autonomy for the Institute, 
striving to overcome the bureaucracy that burdened every state-controlled 
activity. Penicillin was thus a key: the importance of the drugs allowed him 
to request money as well as to quickly hire scientific personnel, without the 
lengthy procedures requested for any other appointment within the Italian 
administrative and academic system. Marotta thus tried to shape the ISS 
according to Anglo-American fashion. At the same time, the state-owned 
penicillin production plant was probably considered by the government as 
a means to gain importance within the wider international context, just like 
the AGIP and later ENI (Ente Nazionale Idrocarburi), the national body for 
hydrocarbons, which in the same period became one of the most important 
players in the global oil market), although on a smaller scale 53. The same 
forces were acting in the international scene where Marotta was playing, 
exploiting the American aids and at the same time gaining autonomy 
 51. The documents regarding the discussion about the fate of the penicillin plant are in ACS - 
ISTISAN DIR, boxes 79 and 86.
 52. Penso, Giuseppe. L’Istituto Superiore di Sanita’ delle origini a oggi. Esegesi storica e prospettive 
per il futuro. Roma: Tipografia regionale; 1964. Penso was one of the two scientists sent to 
Toronto for the penicillin training in 1947.
 53. On the history of ENI a vast bibliography is available, though mostly in Italian. A recent account 
in English language is Carnevali, Francesca. State enterprise and Italy’s «economic miracle»: 
the Ente Nazionale Idrocarburi, 1945-1962. Enterprise and Society. 2000; 1: 249-278.
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from the US at a crucial moment for the country 54. The overall history of 
penicillin production also fits quite well in the wider frame of the policies 
enforced in Italy after WWII with regard to industrial production, as well 
as the strategies followed in the integration into the international economic 
system. These strategies have been termed as «liberal protectionism», and to 
many historians seems a weak compromise. On one side, the Government 
tried to follow the American-sponsored liberalism; on the other, it tried 
to protect some specific interests and to establish some sort of general 
welfare protection 55. 
At least in the early post-war years, the industrial compound was
«unable, with few exceptions, to think their international placing in an strategic 
perspective, wary if not overtly hostile to American directives for liberali-
zation, these being accepted only for the part that allowed the immediate, 
though short term, boost of traditional exports, or when it favoured the flight 
of capital and speculations on currency exchange; yet, it was reluctant when 
confronted with the possibility of opening the national market» 56.
 
At the same time, until the beginning of the 1950s, the government was 
not able to develop a consistent economic and industrial policy. A sound 
planning only emerged in the middle of the decade, with the so-called 
piano Vanoni, the project designed in 1954 by the Government to help the 
development of Italian economy and society by means of strong intervention 
by the state in specific, though wide, sectors 57. The reforms undertaken at 
the beginning of the 1950s and the new scene of the European Common 
Market (with the new trade and tariff system) caused the decline of overt 
protectionism. In this scene, the country entered a period of wild expansion, 
 54. In April 1948, the first general elections were held: the defeat of the Communist Party firmly 
placed the Country in the Western Block.
 55. This opinion is largely shared. See for example Amato, Giuliano, ed. Il governo dell’industria 
in Italia. Testi e documenti. Bologna: Il Mulino; 1972; Cavalcanti, Maria Luisa. La politica 
commerciale italiana, 1945-1952. Uomini e fatti. Napoli: Edizioni scientifiche italiane; 1984; 
Battilossi, Stefano. L’Italia nel sistema economico internazionale. Il management dell’integrazione. 
Finanza, industria e istituzioni, 1945-1955. Milano: FrancoAngeli; 1996.
 56. Battilossi, n. 55, p. 50.
 57. The «piano» was an ample theoretical scheme commissioned by the minister of the treasury 
Ezio Vanoni and elaborated by a think tank in 1954. A main objective of the plan was the 
filling of the wide gap between the North and the South of Italy. About Ezio Vanoni and his 
plan, a comprehensive picture is provided by the first issue of the Rivista SSEF, 2004 (avail-
able at http://rivista.ssef.it/site.php?page=&edition=2004-01-01).
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the so-called «boom» or «economic miracle». The end of this expansion, 
due to several factors and usually situated in 1963-1964, overlaps the onset 
of a new reformist period. In 1962 Italy came to be ruled by a centre-left 
government, which called for stronger state control over the economy and 
nationalised some important sectors, such as electricity.
The crisis at the ISS and the penicillin factory largely overlapped with a 
general crisis experienced by the country. The economy slowed down after 
the boom, social issues related to modernization became manifest, and the 
North-South gap widened. The centre-left alliance proved unable to face the 
new challenges and also had to stand up against attacks coming both from 
the left and the right wing opposition. The prosecutions against Ippolito and 
Marotta should be framed in this context, and the new government failed 
to develop a new science policy and to fruitfully address the relationship 
between industry and science. This led in turn to a general crisis in the 
Italian research system that exploded harshly at the end of the decade 58.
The various stages and steps that led to the steep decline in Italian 
science after the 1960s are not yet fully detailed 59: thus it is not possible to 
draw a comprehensive picture framing the history of scientific institutions 
in the recent history of the country. However, the history of the penicillin 
factory 60 offers an interesting perspective combining the big picture and 
the interaction among single characters. On one hand, the history of the 
penicillin factory is fully embedded in the history of Italy in that period: 
reconstruction, expansion, crisis. On the other hand, the creation of the 
factory was not a mere accessory or a consequence: people like Domenico 
Marotta and Ernst Chain had a vision of the development of science, and 
actively pursued it within an international network of people, institutions 
and ideas, thus trespassing the boundaries of «plain» national politics. 
 58. Ruberti, Antonio. Riflessioni sul sistema della ricerca dopo il 1945. In: Simili, Raffaella, ed. Ricerca 
e istituzioni scientifiche in Italia. Roma: Laterza; 1998, p. 213-230; Capocci, Mauro; Corbellini, 
Gilberto. Adriano Buzzati-Traverso and the foundation of the International Laboratory of 
Genetics and Biophysics in Naples (1962–1969). Stud. Hist. Phil. Biol. & Biomed. Sci. 2002; 33: 
367-391; Capocci, Mauro. The golden age of human genetics in Italy. Journal of Anthropological 
Sciences. 2006; 84: 85-95.
 59. An attempt at reconstructing this history is in Paoloni, Gianni. Il sistema della ricerca nell’Italia 
del Novecento. Aspetti istituzionali e storico-politici. Paper presented at the conference 
La ricerca scientifica in Italia, Napoli, 2003; available at http://www.unisi.it/criss/download/
marcia2004/paoloni.pdf.
 60. Although I must underline that this reconstruction is still a work in progress: many issues 
haven’t been faced yet.
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Ernst Chain took part in the recovery of the country after the war, making 
Rome a «central periphery» 61 for his own research fields. In this respect, 
may Chain’s role be considered as a part of the foreign aid after WWII, just 
like the penicillin factory donated by UNRRA? Clearly this is not the case: 
science is not merely the continuation of politics by other means. As we have 
seen, the political situation allowed Marotta to fully deploy his vision of a 
great biomedical institution, in many ways connected to the surrounding 
society. He shall be credited for his belief in the value-added of science for 
the development of the country. Still, scientific history should be framed 
in the general picture in order to understand the causes of certain choices, 
of certain successes and setbacks. The penicillin factory, with its scientific, 
industrial and cultural content, is a good subject to investigate how science 
and politics related to each other in post-war Italy.
Acknowledgments
This paper is the partial result of a research project conducted jointly with 
Dr. Daniele Cozzoli (Universitat Pompeu Fabra, Barcelona). I owe him 
several interesting suggestions and fruitful criticisms. I wish to thank Dr. 
Fabio De Sio (The Wellcome Trust Centre for the History of Medicine at 
UCL, London) for useful comments. However, all the shortcomings of this 
paper are entirely under my responsibility. I also would like to thank Maria 
Pia De Simone (ACS), Donatella Gentili (ISS Library) and the staff of the 
Archives and Manuscripts Collection of the Wellcome Library (London) 
for the kind help provided, as well as the Leo Pharma Archive for providing 
some documents. ❚
 61. Gemelli, Giuliana. A central periphery: the Naples Stazione Zoologica as an «attractor». In: 
Schneider, William H., ed. Rockefeller philanthropy and modern biomedicine: international 
initiatives from World War I to the Cold War. Bloomington: Indiana University Press; 2002, p. 
184-207.
